2021
DOI: 10.1016/j.rbmo.2020.10.012
|View full text |Cite
|
Sign up to set email alerts
|

A multi-centre international study of salivary hormone oestradiol and progesterone measurements in ART monitoring

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 30 publications
0
11
0
Order By: Relevance
“…Salimetrics (2020Salimetrics ( , 2019 additionally reported time series for one woman with daily progesterone and estradiol assays in serum and saliva for one cycle, which visually show some parallelism. Compared to Salimetrics' (2020Salimetrics' ( , 2019 numbers, independent validations often show smaller saliva-serum correlations; estimates vary widely, and are poorer at lower concentrations (Tivis et al 2005;Shirtcliff et al 2000;Dielen et al 2017;Sun et al 2019;Lu et al 1999;Sakkas et al 2021). The assay manufacturers IBL and Salimetrics do not report raw data of validation studies and only minimal information on the sample of women and their cycles and only rarely show scatter plots which would allow the assessment of heteroskedasticity and influential outliers.…”
Section: Introductionmentioning
confidence: 99%
“…Salimetrics (2020Salimetrics ( , 2019 additionally reported time series for one woman with daily progesterone and estradiol assays in serum and saliva for one cycle, which visually show some parallelism. Compared to Salimetrics' (2020Salimetrics' ( , 2019 numbers, independent validations often show smaller saliva-serum correlations; estimates vary widely, and are poorer at lower concentrations (Tivis et al 2005;Shirtcliff et al 2000;Dielen et al 2017;Sun et al 2019;Lu et al 1999;Sakkas et al 2021). The assay manufacturers IBL and Salimetrics do not report raw data of validation studies and only minimal information on the sample of women and their cycles and only rarely show scatter plots which would allow the assessment of heteroskedasticity and influential outliers.…”
Section: Introductionmentioning
confidence: 99%
“…Various strategies intent on reducing the number of injections by utilizing long-acting gonadotropins or oral medications are already available and are gaining increased acceptance in the field for the treatment of select patient populations [ 10 , 11 ]. Similarly, an emerging strategy to measure salivary estradiol levels may help decrease the need for blood draws during COH [ 12 ]. Recent advancements in portable lower cost ultrasound devices may further simplify follicular and endometrial monitoring by way of convenient mobile facilities and potentially even self-operated endovaginal telemonitoring [ 13 ].…”
Section: Medical Advancementsmentioning
confidence: 99%
“…Salivary tests, like urine tests, are a non-invasive option for home hormone monitoring [ 70 ]. Despite the similar benefits of these methods, salivary assays may be less convenient to patients, since the samples must be sent to a laboratory as the assay (enzyme-linked immunosorbent assay) cannot be done at home [ 5 , 70 ]. This then adds to the time that clinicians and patients will have to wait for test results to become available.…”
Section: Urine-based Hormonal Assaysmentioning
confidence: 99%
“…This then adds to the time that clinicians and patients will have to wait for test results to become available. Like urinary tests, salivary E2 correlates well with serum E2; however, salivary P4 correlates poorly with serum P4, decreasing the potential applications of this measurement [ 5 ].…”
Section: Urine-based Hormonal Assaysmentioning
confidence: 99%